A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings
Cassidy Henegar(ViiV Healthcare (Spain)), Vani Vannappagari, Emilio Letang(ViiV Healthcare (Spain)), Bryn Jones(ViiV Healthcare (United Kingdom)), Charles B. Hicks(Indiana University School of Medicine), Ruolan Wang(Wuhan National Laboratory for Optoelectronics), Dainielle Fox, Annemiek de Ruiter(ViiV Healthcare (Spain))
Cited by 13
Related Papers
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397